Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas

Nature Communications

Volumn 7, Issue , 2016, Pages

  Kamoun, Aurélie ^a   Idbaih, Ahmed ^b,c,d,e   Dehais, Caroline ^e   Elarouci, Nabila ^a   Carpentier, Catherine ^b,c,d   Letouzé, Eric ^a   Colin, Carole ^f   Mokhtari, Karima ^b,c,d,e   Jouvet, Anne ^g   Uro Coste, Emmanuelle ^h   Martin Duverneuil, Nadine ^e   Sanson, Marc ^b,c,d,e   Delattre, Jean Yves ^b,c,d,e   Figarella Branger, Dominique ^f,i   De Reyniès, Aurélien ^a   Ducray, François ^g,j,k   Adam, Clovis ^l   Andraud, Marie ^m   Aubriot Lorton, Marie Hélène ⁿ   Bauchet, Luc ^o   Beauchesne, Patrick ^p   Bielle, Franck ^e   Blechet, Claire ^q   Campone, Mario ^r   Carpentier, Antoine F ^s   Carpiuc, Ioana ^t   Cazals Hatem, Dominique ^u   Chenard, Marie Pierre ^v   Chiforeanu, Danchristian ^w   Chinot, Olivier ⁱ   Cohen Moyal, Elisabeth ^x   Colin, Philippe ^y   Dam Hieu, Phong ^z   Desenclos, Christine ^aa   Desse, Nicolas ^ab   Dhermain, Frederic ^ac   Diebold, Marie Danièle ^ad   Eimer, Sandrine ^ae   Faillot, Thierry ^u   Fesneau, Mélanie ^q   Fontaine, Denys ^af   Gaillard, Stéphane ^ag   Gauchotte, Guillaume ^p   Gaultier, Claude ^ah   Ghiringhelli, François ^ai   Godard, Joel ^aj   Gueye, Edouard Marcel ^ak   Guillamo, Jean Sebastien ^al   Hamdi Elouadhani, Selma ^am   Honnorat, Jerome ^g   Kemeny, Jean Louis ^an   Khallil, Toufik ^an   Labrousse, François ^ak   Langlois, Olivier ^ao   Laquerriere, Annie ^ao   Larrieu Ciron, Delphine ^ap   Lechapt Zalcman, Emmanuelle ^al   Le Guérinel, Caroline ^aq   Levillain, Pierre Marie ^ap   Loiseau, Hugues ^ae   Loussouarn, Delphine ^ar   Maurage, Claude Alain ^as   Menei, Philippe ^at   Fotso, Marie Janette Motsuo ^au   Noel, Georges ^av   Parker, Fabrice ^l   Peoc'h, Michel ^au   Polivka, Marc ^am   Quintin Roué, Isabelle ^z   Ramirez, Carole ^as   Ricard, Damien ^aw   Richard, Pomone ^ax   Rigau, Valérie ^o   Rousseau, Audrey ^at   Runavot, Gwenaelle ^m   Sevestre, Henri ^aa   Tortel, Marie Christine ^u   Vandenbos, Fanny ^af   Vauleon, Elodie ^ay   Viennet, Gabriel ^aj   Villa, Chiara ^ag   more..

^a Programme Cartes d'Identite des Tumeurs CIT   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d CNRS   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f AIX MARSEILLE UNIVERSITY   (France)

^g HÔPITAL NEUROLOGIQUE   (France)

^h CHU RANGUEIL   (France)

ⁱ TIMONE HOSPITAL   (France)

^j CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^k UNIVERSITÉ LYON 1   (France)

^l BICÊTRE HOSPITAL   (France)

^m Groupe Hospitalier Sud Réunion   (France)

ⁿ DIJON UNIVERSITY HOSPITAL   (France)

^o MONTPELLIER UNIVERSITY HOSPITAL   (France)

^p UNIVERSITY HOSPITAL OF NANCY   (France)

^q CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^r CENTRE RENÉ GAUDUCHEAU   (France)

^s AVICENNE HOSPITAL   (France)

^t Clinique des Cedres   (France)

^u BEAUJON HOSPITAL   (France)

^v UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^w RENNES UNIVERSITY HOSPITAL   (France)

^x INSTITUT CLAUDIUS REGAUD   (France)

^y Clinique de Courlancy   (France)

^z SERVICE DE RHUMATOLOGIE   (France)

^aa AMIENS UNIVERSITY HOSPITAL   (France)

^ab Military Teaching Hospital Sainte Anne   (France)

^ac INSTITUT GUSTAVE ROUSSY   (France)

^ad REIMS UNIVERSITY HOSPITAL   (France)

^ae BORDEAUX UNIVERSITY HOSPITAL   (France)

^af UNIVERSITY HOSPITAL OF NICE   (France)

^ag FOCH HOSPITAL   (France)

^ah Service de Neurologie/CH de Colmar   (France)

^ai CENTRE GEORGES FRANÇOIS LECLERC   (France)

^aj UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^ak DUPUYTREN UNIVERSITY HOSPITAL   (France)

^al CAEN UNIVERSITY HOSPITAL   (France)

^am HÔPITAL LARIBOISIÈRE   (France)

^an UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^ao HÔPITAL CHARLES NICOLLE   (France)

^ap POITIERS UNIVERSITY HOSPITAL   (France)

^aq HENRI MONDOR HOSPITAL   (France)

^ar NANTES UNIVERSITY HOSPITAL   (France)

^as LILLE UNIVERSITY HOSPITAL   (France)

^at ANGERS UNIVERSITY HOSPITAL   (France)

^au HÔPITAL NORD   (France)

^av CENTRE PAUL STRAUSS   (France)

^aw University of Paris Descartes   (France)

^ax Pathology Department   (France)

^ay CENTRE EUGÈNE MARQUIS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 34B; MICRORNA 34C; MYC PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; MYC PROTEIN, HUMAN;

BIOINFORMATICS; GENETIC ANALYSIS; GENOMICS; MUTATION; NERVOUS SYSTEM DISORDER; TUMOR;

ADULT; ARTICLE; CANCER SURVIVAL; CHROMOSOME 19Q; CHROMOSOME DELETION; CHROMOSOME DELETION 19Q; CHROMOSOME DELETION 1P; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; NERVOUS SYSTEM TUMOR; NEURONAL LINEAGE TUMOR; OLIGODENDROCYTE PRECURSOR CELL TUMOR; OLIGODENDROCYTE TUMOR; OVERALL SURVIVAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; TUMOR GROWTH; AGED; CHROMOSOME 1; CHROMOSOME 19; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PROCEDURES; SIGNAL TRANSDUCTION; STEM CELL; SURVIVAL ANALYSIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; CLUSTER ANALYSIS; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEURONS; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; STEM CELLS; SURVIVAL ANALYSIS; TRANSCRIPTOME; YOUNG ADULT;

EID: 84973326510     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11263     Document Type: Article

References (51)

1. Ricard, D. et al. Primary brain tumours in adults. Lancet Lond. Engl 379, 1984-1996 (2012).
2. Wesseling, P., van den Bent, M. & Perry, A. Oligodendroglioma: pathology, molecular mechanisms and markers. Acta Neuropathol. (Berl.) 129, 809-827 (2015).
3. van den Bent, M. J. et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 31, 344-350 (2013).
4. Cairncross, J. G. et al. Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 32, 783-790 (2014).
5. Cancer Genome Atlas Research Network et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372, 2481-2498 (2015).
6. Reuss, D. E. et al. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an 'integrated' diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol. (Berl.) 129, 133-146 (2015).
7. Louis, D. N. et al. International Society Of Neuropathology - Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol. Zurich Switz 24, 429-435 (2014).
8. Gravendeel, L. A. M. et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res. 69, 9065-9072 (2009).
9. Madhavan, S. et al. Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol. Cancer Res 7, 157-167 (2009).
10. Verhaak, R. G. W. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98-110 (2010).
11. Chen, Y. et al. The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat. Neurosci. 12, 1398-1406 (2009).
12. Matsumura, N. et al. Coexpression of cyclin D1 and alpha-internexin in oligodendroglial tumors. Brain Tumor Pathol. 32, 261-267 (2015).
13. Cahoy, J. D. et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. Off. J. Soc. Neurosci. 28, 264-278 (2008).
14. Lein, E. S. et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168-176 (2007).
15. Dougherty, J. D. et al. Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma. Cancer Res. 72, 4856-4868 (2012).
16. Nevo, I. et al. Identification of molecular pathways facilitating glioma cell invasion in situ. PloS ONE 9, e111783 (2014).
17. Tso, C.-L. et al. Primary glioblastomas express mesenchymal stem-like properties. Mol. Cancer Res. MCR 4, 607-619 (2006).
18. Cascón, A. & Robledo, M. MAX and MYC: a heritable breakup. Cancer Res. 72, 3119-3124 (2012).
19. Stephenson, J., Akdag, R., Ozbek, N. & Mufti, G. J. Methylation status within exon 3 of the c-myc gene as a prognostic marker in myeloma and leukaemia. Leuk. Res. 17, 291-293 (1993).
20. Sharrard, R. M., Royds, J. A., Rogers, S. & Shorthouse, A. J. Patterns of methylation of the c-myc gene in human colorectal cancer progression. Br. J. Cancer 65, 667-672 (1992).
21. Lujambio, A. et al. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl Acad. Sci. USA. 105, 13556-13561 (2008).
22. Leucci, E. et al. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J. Pathol. 216, 440-450 (2008).
23. Hermeking, H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 17, 193-199 (2010).
24. Hsiao, H. et al. Quantitative characterization of the interactions among c-myc transcriptional regulators FUSE, FBP, and FIR. Biochemistry (Mosc.) 49, 4620-4634 (2010).
25. Eckel-Passow, J. E. et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N. Engl. J. Med. 372, 2499-2508 (2015).
26. Bai, H. et al. Integrated genomic characterization of IDH1-mutant glioma malignant progression. Nat. Genet. advance online publication 48, 59-66 (2015).
27. Persson, A. I. et al. Non-stem cell origin for oligodendroglioma. Cancer Cell 18, 669-682 (2010).
28. Tsoa, R. W., Coskun, V., Ho, C. K., de Vellis, J. & Sun, Y. E. Spatiotemporally different origins of NG2 progenitors produce cortical interneurons versus glia in the mammalian forebrain. Proc. Natl Acad. Sci. USA. 111, 7444-7449 (2014).
29. Fumagalli, M. et al. The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G protein-coupled receptor kinase 2 in the regulation of GPR17 receptor desensitization. Glia 63, 2327-2339 (2015).
30. Hennen, S. et al. Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist. Sci. Signal. 6, ra93 (2013).
31. Comino-Méndez, I. et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat. Genet. 43, 663-667 (2011).
32. Enciso-Mora, V. et al. Deciphering the 8q24.21 association for glioma. Hum. Mol. Genet 22, 2293-2302 (2013).
33. Crossen, P. E. & Morrison, M. J. Methylation status of the 3rd exon of the c-MYC oncogene in B-cell malignancies. Leuk. Res. 23, 251-253 (1999).
34. Mertz, J. A. et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc. Natl Acad. Sci. USA. 108, 16669-16674 (2011).
35. Figarella-Branger, D. et al. Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations. Neuro-Oncol. 16, 1244-1254 (2014).
36. Alentorn, A. et al. Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas. Neurology 85, 1325-1331 (2015).
37. Odia, Y., Orr, B. A., Bell, W. R., Eberhart, C. G. & Rodriguez, F. J. cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome. J. Neurooncol. 115, 249-259 (2013).
38. Louis, D. N. et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. (Berl.) 114, 97-109 (2007).
39. Staaf, J. et al. Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios. BMC Bioinformatics 9, 409 (2008).
40. Venkatraman, E. S. & Olshen, A. B. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinforma. Oxf. Engl 23, 657-663 (2007).
41. Popova, T. et al. Genome alteration print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays. Genome Biol. 10, R128 (2009).
42. Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinforma. Oxf. Engl 26, 1572-1573 (2010).
43. Ritchie, M. E. et al. limma powers differential expression analyses for RNAsequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
44. Hinoue, T. et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 22, 271-282 (2012).
45. Vigneault, F. et al. High-throughput multiplex sequencing of miRNA. Curr. Protoc. Hum. Genet. Chapter 11, Unit 11.12.1-10 (2012).
46. Wang, W.-C. et al. miRExpress: analyzing high-throughput sequencing data for profiling microRNA expression. BMC Bioinformatics 10, 328 (2009).
47. Hackenberg, M., Rodríguez-Ezpeleta, N. & Aransay, A. M. miRanalyzer: an update on the detection and analysis of microRNAs in high-throughput sequencing experiments. Nucleic Acids Res. 39, W132-W138 (2011).
48. Gleize, V. et al. CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas. Ann. Neurol. 78, 355-374 (2015).
49. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005).
50. Dieterich, L. C. et al. Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFb2 in vascular abnormalization. J. Pathol. 228, 378-390 (2012).
51. Zeller, K. I., Jegga, A. G., Aronow, B. J., O'Donnell, K. A. & Dang, C. V. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol. 4, R69 (2003).